ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,028Medicare Part D Prescriptions Filled, Including Refills

Rank: 31 out of 1000

$807K Total Retail Price of All Prescriptions

Rank: 103 out of 1000

810 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
51% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 810 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

27% of this provider’s 810 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

4% of this provider’s 17,334 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$34 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 1,258 669 S3 1 1
LISINOPRIL 779 545 2 5
OMEPRAZOLE 779 562 2 2
LEVOTHYROXINE SODIUM 671 447 4 4
METFORMIN HCL 650 452 5 8
FUROSEMIDE 647 473 6 7
SIMVASTATIN 614 475 7 3
MELOXICAM 605 455 8 14
AMLODIPINE BESYLATE 510 407 9 6
METOPROLOL TARTRATE 473 356 10 19
TRAMADOL HCL 464 318 11 13
POTASSIUM CHLORIDE 446 339 12 10
METOPROLOL SUCCINATE 409 333 13 21
GABAPENTIN 393 238 14 11
PRAVASTATIN SODIUM 352 280 15 12
ATENOLOL 329 280 16 24
SERTRALINE HCL 310 198 17 26
WARFARIN SODIUM 255 214 18 22
FLUTICASONE PROPIONATE 243 174 19 40
CITALOPRAM HBR 241 157 20 17
LOSARTAN POTASSIUM 224 179 21 25
DONEPEZIL HCL 221 199 22 32
AMLODIPINE BESYLATE-BENAZEPRIL 220 202 23 59
ATORVASTATIN CALCIUM 215 178 24 18
HYDROCHLOROTHIAZIDE 211 166 25 9
NEXIUM 210 121 26 23
TAMSULOSIN HCL 204 179 27 33
CARBIDOPA-LEVODOPA 202 143 28 116
TRAZODONE HCL 202 80 28 29
CYCLOBENZAPRINE HCL 194 100 R 30 39
ALENDRONATE SODIUM 191 180 31 57
BENAZEPRIL HCL 190 122 32 61
GLIMEPIRIDE 186 129 33 34
ZOLPIDEM TARTRATE 179 132 34 16
ENALAPRIL MALEATE 175 149 35 58
ALLOPURINOL 173 153 36 31
PANTOPRAZOLE SODIUM 172 123 37 28
CLONIDINE HCL 170 118 38 27
METHOCARBAMOL 160 92 R 39 79
CARVEDILOL 160 136 39 15
TRIAMTERENE-HYDROCHLOROTHIAZID 148 135 41 194
CLOPIDOGREL 143 93 42 35
JANUVIA 143 95 42 85
SULFAMETHOXAZOLE-TRIMETHOPRIM 142 93 44 70
DICYCLOMINE HCL 139 100 45 197
LISINOPRIL-HYDROCHLOROTHIAZIDE 136 122 46 20
AMITRIPTYLINE HCL 135 108 R 47 45
GLIPIZIDE 128 86 48 62
BUMETANIDE 128 101 48 112
TRIAMTERENE-HCTZ 126 99 50 48
PAROXETINE HCL 117 78 51 63
CRESTOR 115 105 52 30
AZITHROMYCIN 113 75 53 36
GLIPIZIDE ER 109 89 54 106
MECLIZINE HCL 107 97 55 80
DICLOFENAC SODIUM 105 100 56 123
ACETAMINOPHEN-CODEINE 103 86 S3 57 127
KLOR-CON M20 103 85 57 66
CIPROFLOXACIN HCL 102 77 59 46
TERAZOSIN HCL 101 93 60 150
SUCRALFATE 101 73 60 144
DILTIAZEM 24HR CD 99 77 62 136
PREDNISONE 99 71 62 42
GEMFIBROZIL 96 68 64 105
QUINAPRIL HCL 95 72 65 117
ETODOLAC 94 65 66 152
ISOSORBIDE MONONITRATE ER 93 93 67 71
LOSARTAN-HYDROCHLOROTHIAZIDE 93 88 67 38
PRAMIPEXOLE DIHYDROCHLORIDE 92 47 69 147
LOVASTATIN 90 75 70 41
DILTIAZEM ER 87 71 71 146
OXYBUTYNIN CHLORIDE 87 54 71 145
TRICOR 87 61 71 141
IBUPROFEN 85 56 74 94
TRIAMCINOLONE ACETONIDE 83 62 75 159
VERAPAMIL ER 81 65 76 86
FLUOXETINE HCL 80 44 77 51
SPIRIVA 79 63 78 64
PLAVIX 79 50 78 49
ADVAIR DISKUS 78 49 80 65
PROMETHAZINE HCL 76 27 R 81 54
VENTOLIN HFA 74 59 82 83
CILOSTAZOL 74 68 82 227
LEVOFLOXACIN 73 58 84 73
DIGOXIN 72 72 85 52
CELEBREX 71 50 86 98
METFORMIN HCL ER 71 54 86 44
FLUCONAZOLE 69 39 88 102
SPIRONOLACTONE 68 61 89 78
ESTRADIOL 68 51 R 89 114
HYDROXYZINE HCL 67 26 R 91 153
NAPROXEN 66 49 92 81
DOXAZOSIN MESYLATE 66 65 92 111
METHYLPREDNISOLONE 66 46 92 103
RANITIDINE HCL 65 41 95 37
CEFDINIR 64 43 96 122
TORSEMIDE 63 61 97 137
VENLAFAXINE HCL ER 62 26 98 124
KLOR-CON 10 61 43 99 104
CYPROHEPTADINE HCL 61 61 R 99 297
LYRICA 61 27 99 47
DIOVAN 60 33 102 67
PREMARIN 58 44 R 103 109
HYDROXYZINE PAMOATE 56 0 R 104 234
BUPROPION HCL SR 55 30 105 183
FENOFIBRATE 53 42 106 55
DIPYRIDAMOLE 53 40 R 106 311
NITROFURANTOIN 53 42 106 199
METOLAZONE 51 32 109 167
DILTIAZEM 24HR ER 50 49 110 189
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 10, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.